- Angry French cognac makers see red over Chinese tariffs threat
- Protect the prosciutto: Italy battles swine fever
- UN holds 'Summit of the Future' to tackle global crises
- Marxist leader set to become Sri Lanka's next president
- From blades to pull-up bars: UK charity tackles knife crime
- Swiss vote on pensions and environment protections
- No pain, no gain: Chinese pro wrestlers fight for recognition
- UAE leader seeks to deepen 'strategic' ties in US visit during Mideast crisis
- Hezbollah takes heavy hits but still fighting Israel
- Floods, landslides hit central Japan months after major quake
- All Blacks coach Robertson demands better finishing
- Argentina edge South Africa to keep title hopes alive
- Biden says China 'testing us,' in hot mic remarks to Quad allies
- Dubois destroys Joshua to retain IBF world heavyweight crown
- Guardiola says critics want Man City wiped 'from face of the Earth'
- Biden says 'Quad' is 'here to stay' despite challenges
- Dubois knocks out Joshua to retain IBF world heavyweight crown
- Vinicius helps 'faster' Madrid overturn stubborn Espanyol
- Zelensky to press US on long-range missile strikes inside Russia
- PSG drop first points in draw at Reims
- Vinicius, Mbappe on target as Madrid crush plucky Espanyol
- Jeeno leads Ko by two at LPGA Queen City Championship
- Bottega Veneta goes for 'E.T.' chic as Madonna pops into D&G
- Messi, Miami frustrated by New York late leveler
- Musk's X platform takes first step toward lifting Brazil ban
- 'Business as usual' for Australia match-winner Carey amid boos
- Israeli jets pound Lebanon after deadly Beirut strike
- Ten Hag bemoans Man Utd's lack of killer instinct in Palace stalemate
- France's Macron appoints new government in shift to right
- Cheika proud of Leicester grit after winning start as boss
- Profligate Man Utd pay price in 0-0 draw at Palace
- Kane, Olise run riot as Bayern thump Bremen
- Diaz fires Liverpool top of Premier League, Man Utd held at Palace
- LIV champion Rahm out of LIV Team semis with severe flu
- Slot surprised by tearful Nunez's moment of magic
- Title rivals Norris, Verstappen on 'cool' front row for Singapore GP
- Biden talks China with 'Quad' leaders in hometown summit
- Juve and Napoli play out goalless draw in early Serie A title tussle
- Alcaraz fears tennis tour grind will 'kill us'
- Carey sparks recovery as Australia thrash England in 2nd ODI
- Leclerc, Sainz lament 'disappointing' Saturday in Singapore
- Bottega Veneta holds investors' aces as Madonna pops into D&G
- Beirut digs for victims at building flattened in Israeli strike
- Verstappen stages protest over 'ridiculous' swearing punishment
- Bayern boss Kompany lauds 'special talent' Olise
- Diaz fires Liverpool top of Premier League, Spurs bounce back
- Heavy fire over Israel-Lebanon border after deadly Beirut strike
- Ramos guides unbeaten Toulouse to Montpellier win despite Hogg scuffle
- Myanmar flood death toll jumps to 384
- Chelsea owners 'happy' with win at West Ham amid rift report
Philips take hit by supply problems, respirator recall
Philips on Monday reported net losses of over 150 million euros in the first quarter of 2022 as the Dutch health technology firm battled a faulty respirator recall and supply chain problems.
The Amsterdam-based firm, which has sold off its domestic appliance arm to focus on medical equipment, said sales fell by 4 percent to 3.918 billion euros ($4.2 billion).
The first quarter losses were in stark contrast to the 40-million-euro profit the year before.
"We recorded better than expected sales... in very challenging circumstances," Philips chief executive Frans van Houten said, maintaining a positive spin.
But there were "significant supply chain headwinds as well as the consequences of the Respironics field action," Van Houten said.
Philips set aside a further 165 million euros to recall faulty respiratory equipment that puts users at risk of inhaling toxic foam.
The company previously reserved 725 million euros to fix the problem.
Philips said it was replacing and repairing devices "as fast as possible and are continuing to update patients and customers about the progress of the program".
The devices are mainly for use in the home for patients with problems such as sleep apnoea, a disorder in which breathing stops and starts.
Philips recalled them in June last year after announcing that users were at risk of inhaling or swallowing pieces of degraded sound-dampening foam.
"We are committed to supporting the community of patients who rely on our sleep and respiratory care solutions for their health and quality of life, and the physicians and customers who are dedicated to meeting patient needs," Van Houten said.
Philips and a number of its subsidiaries however were subpoenaed earlier this month by the US Justice Department "to provide information related to events leading to the Respironics recall" it said.
"The relevant subsidiaries are cooperating with the agency," Van Houten said.
Philips' share price plunged around 11 percent in early afternoon trade on the Amsterdam stock exchange's AEX index to around 25 euros per share.
jhe/ach
J.Fankhauser--BTB